Covington Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Covington Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$121K	Sell	176 -25	-12%	-$15.7K	0.01%	428
2022 Q2	$119K	Sell	201 -806	-80%	-$524K	﹤0.01%	435
2022 Q1	$704K	Buy	1,007 +762	+311%	+$482K	0.03%	269
2021 Q4	$155K	Hold	245	–	–	0.01%	388
2021 Q3	$148K	Buy	245 +1	+0.4%	+$621	0.01%	384
2021 Q2	$136K	Buy	244 +243	+24,300%	+$123K	0.01%	403
2021 Q1	$0	Buy	+1	New	+$487	﹤0.01%	877
2020 Q2	–	Sell	-65	Closed	-$32K	–	789
2020 Q1	$32K	Buy	65 +55	+550%	+$22.7K	﹤0.01%	472
2019 Q4	$4K	Buy	+10	New	+$3.36K	﹤0.01%	815
2018 Q1	–	Sell	-101	Closed	-$38K	–	768
2017 Q4	$38K	Buy	101 +13	+15%	+$5.26K	﹤0.01%	487
2017 Q3	$39K	Buy	+88	New	+$41.9K	﹤0.01%	462

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Covington Capital Management's REGN Position: Q3 2022 in Review

Covington Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q3 2022, selling an estimated $15.7K and leaving 176 shares worth $121K. The position accounts for 0.01% of the portfolio, ranked #428.

Covington Capital Management first reported a position in REGN in Q3 2017 and has held it in 11 quarters since. The position peaked at $704K in Q1 2022. 1,081 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

Covington Capital Management held 176 shares of Regeneron Pharmaceuticals worth $121K as of Q3 2022.
Covington Capital Management sold 25 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $15.7K.
Regeneron Pharmaceuticals made up 0.01% of Covington Capital Management's portfolio in Q3 2022, its #428 holding.
Covington Capital Management first reported a position in Regeneron Pharmaceuticals in Q3 2017 and has held it in 11 quarters since.
Covington Capital Management's Regeneron Pharmaceuticals position peaked at $704K in Q1 2022.
1,081 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.